|
|||||
|
|
A national survey of hospital-based transfusion services on their approaches to platelet bacterial risk mitigation in response to the FDA final guidance for industry |
|
| Authors: | Wen Lu Meghan Delaney Nancy M. Dunbar Susan N. Rossmann Mark Fung |
| Affiliation: | 1. Robert Tomsich Pathology & Laboratory Medicine Institute, Cleveland Clinic, Cleveland, Ohio, USA;2. Pathology and Laboratory Medicine, Childrenʼs National Hospital, Washington, DC, USA;3. Department of Pathology and Laboratory Medicine, Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire, USA;4. Gulf Coast Regional Blood Center, Houston, Texas, USA;5. Department of Pathology and Laboratory Medicine, University of Vermont Medical Center, Burlington, Vermont, USA |
| Abstract: | |
| Keywords: | |